Structure-Activity Relationship Inference and Virtual Screening at Scale: The Role of AI-Powered Platforms in Transforming Modern Drug Discovery

Authors

  • Veronica Murillo Associate Professor of Computer Science, Tecnológico de Costa Rica Author

Keywords:

structure-activity relationship inference, virtual screening at scale, the role, platforms, machine learning

Abstract

Introduction Artificial intelligence (AI) platforms designed for drug discovery have made significant improvements over traditional methodologies. Given the very high attrition rates in the pharmaceutical industry, relying on traditional drug discovery methods has not been overly conducive to innovation. These results are not wholly surprising, given that traditional methods such as high-throughput screening and lead optimization have not significantly changed in decades.

Readership Data

🌐

Refreshing Cached Analytics Data

The cached analytics data has become stale and www.thesciencebrigade.com is making a fresh request to fetch the latest data from Google Analytics. This may take 20-30 seconds depending on the server response time from Google Analytics. Please do not close the browser during this time. We appreciate your patience.

Downloads

Download data is not yet available.

Downloads

Published

31-10-2025

How to Cite

“Structure-Activity Relationship Inference and Virtual Screening at Scale: The Role of AI-Powered Platforms in Transforming Modern Drug Discovery”. Journal of Science & Technology, vol. 6, no. 5, Oct. 2025, pp. 49-56, https://www.thesciencebrigade.com/jst/article/view/710.

Plaudit